First Allied Advisory Services’s AstraZeneca AZN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2020
Q3
$1.91M Buy
34,774
+21,521
+162% +$1.18M 0.06% 306
2020
Q2
$701K Buy
13,253
+2,409
+22% +$127K 0.03% 550
2020
Q1
$484K Sell
10,844
-1,764
-14% -$78.7K 0.02% 602
2019
Q4
$627K Sell
12,608
-388
-3% -$19.3K 0.02% 631
2019
Q3
$576K Buy
12,996
+2,853
+28% +$126K 0.02% 637
2019
Q2
$419K Buy
10,143
+385
+4% +$15.9K 0.01% 740
2019
Q1
$389K Sell
9,758
-6,961
-42% -$277K 0.01% 756
2018
Q4
$633K Sell
16,719
-1,788
-10% -$67.7K 0.03% 538
2018
Q3
$739K Sell
18,507
-1,707
-8% -$68.2K 0.03% 569
2018
Q2
$714K Sell
20,214
-1,345
-6% -$47.5K 0.03% 556
2018
Q1
$752K Sell
21,559
-2,286
-10% -$79.7K 0.03% 534
2017
Q4
$825K Buy
23,845
+1,694
+8% +$58.6K 0.03% 498
2017
Q3
$750K Buy
22,151
+2,726
+14% +$92.3K 0.03% 489
2017
Q2
$663K Sell
19,425
-960
-5% -$32.8K 0.03% 532
2017
Q1
$666K Buy
20,385
+4,056
+25% +$133K 0.03% 497
2016
Q4
$446K Sell
16,329
-1,987
-11% -$54.3K 0.02% 623
2016
Q3
$602K Buy
18,316
+6,807
+59% +$224K 0.03% 504
2016
Q2
$343K Sell
11,509
-2,567
-18% -$76.5K 0.02% 690
2016
Q1
$397K Sell
14,076
-429
-3% -$12.1K 0.02% 631
2015
Q4
$488K Buy
14,505
+623
+4% +$21K 0.03% 586
2015
Q3
$443K Buy
13,882
+390
+3% +$12.4K 0.02% 593
2015
Q2
$430K Buy
13,492
+4,926
+58% +$157K 0.02% 667
2015
Q1
$292K Sell
8,566
-2,618
-23% -$89.2K 0.02% 791
2014
Q4
$392K Buy
11,184
+1,600
+17% +$56.1K 0.03% 615
2014
Q3
$342K Buy
+9,584
New +$342K 0.03% 669
2014
Q2
Sell
-11,474
Closed -$369K 1006
2014
Q1
$369K Sell
11,474
-76,046
-87% -$2.45M 0.03% 629
2013
Q4
$2.62M Sell
87,520
-99,336
-53% -$2.97M 0.21% 139
2013
Q3
$4.89M Buy
186,856
+64,764
+53% +$1.7M 0.28% 103
2013
Q2
$2.89M Buy
+122,092
New +$2.89M 0.23% 129